State of Illinois
91st General Assembly
Legislation

   [ Search ]   [ Legislation ]
[ Home ]   [ Back ]   [ Bottom ]


[ Introduced ][ Engrossed ]

91_HB1801ham001

 










                                             LRB9105700ACtmam

 1                    AMENDMENT TO HOUSE BILL 1801

 2        AMENDMENT NO.     .  Amend House Bill 1801  by  replacing
 3    everything after the enacting clause with the following:

 4        "Section 5.  The Pharmacy Practice Act of 1987 is amended
 5    by changing Section 3 as follows:

 6        (225 ILCS 85/3) (from Ch. 111, par. 4123)
 7        Sec.  3.  Definitions.   For the purposes purpose of this
 8    Act, except where otherwise limited therein:
 9        (a)  "Pharmacy" or "drugstore" means and  includes  every
10    store,  shop,  pharmacy  department,  or  other  place  where
11    pharmaceutical  care  is  provided  by a pharmacist (1) where
12    drugs, medicines, or poisons are dispensed, sold  or  offered
13    for  sale  at retail, or displayed for sale at retail; or (2)
14    where prescriptions of physicians,  dentists,  veterinarians,
15    podiatrists,   or   therapeutically  certified  optometrists,
16    within the limits of their licenses, are compounded,  filled,
17    or  dispensed;  or  (3) which has upon it or displayed within
18    it, or affixed to or used  in  connection  with  it,  a  sign
19    bearing   the   word   or   words  "Pharmacist",  "Druggist",
20    "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore",
21    "Medicine Store", "Prescriptions", "Drugs",  "Medicines",  or
22    any  word  or  words of similar or like import, either in the
 
                            -2-              LRB9105700ACtmam
 1    English language or any other  language;  or  (4)  where  the
 2    characteristic  prescription  sign  (Rx) or similar design is
 3    exhibited; or (5) any store, or shop,  or  other  place  with
 4    respect  to  which  any of the above words, objects, signs or
 5    designs are used in any advertisement.
 6        (b)  "Drugs" means and includes (l)  articles  recognized
 7    in   the   official   United   States  Pharmacopoeia/National
 8    Formulary (USP/NF),  or  any  supplement  thereto  and  being
 9    intended  for  and  having  for their main use the diagnosis,
10    cure, mitigation, treatment or prevention of disease  in  man
11    or  other  animals, as approved by the United States Food and
12    Drug Administration, but does not include  devices  or  their
13    components, parts, or accessories; and (2) all other articles
14    intended  for  and  having  for their main use the diagnosis,
15    cure, mitigation, treatment or prevention of disease  in  man
16    or  other  animals, as approved by the United States Food and
17    Drug Administration, but does not include  devices  or  their
18    components,  parts,  or  accessories; and (3) articles (other
19    than food) having for their main use and intended  to  affect
20    the  structure  or  any  function of the body of man or other
21    animals; and (4) articles  having  for  their  main  use  and
22    intended  for use as a component or any articles specified in
23    clause (l), (2) or (3); but does not include devices or their
24    components, parts or accessories.
25        (c)  "Medicines" means and includes  all  drugs  intended
26    for  human  or  veterinary  use approved by the United States
27    Food and Drug Administration.
28        (d)  "Practice  of  pharmacy"  means  the  provision   of
29    pharmaceutical   care   to  patients  as  determined  by  the
30    pharmacist's professional judgment in  the  following  areas,
31    which  may  include  but  are  not  limited  to  (1)  patient
32    counseling,   (2)   interpretation   and   assisting  in  the
33    monitoring of  appropriate  drug  use  and  prospective  drug
34    utilization   review,   (3)   providing  information  on  the
 
                            -3-              LRB9105700ACtmam
 1    therapeutic  values,  reactions,  drug   interactions,   side
 2    effects,  uses, selection of medications and medical devices,
 3    and outcome  of  drug  therapy,  (4)  participation  in  drug
 4    selection,   drug   monitoring,   drug   utilization  review,
 5    evaluation, administration,  interpretation,  application  of
 6    pharmacokinetic  and  laboratory  data  to  design  safe  and
 7    effective  drug  regimens,  (5)  drug  research (clinical and
 8    scientific), and (6) compounding and dispensing of drugs  and
 9    medical devices.
10        (e)  "Prescription" means and includes any written, oral,
11    facsimile,  or  electronically transmitted order for drugs or
12    medical devices, issued by a physician licensed  to  practice
13    medicine  in  all  its  branches,  dentist,  veterinarian, or
14    podiatrist,  or therapeutically certified optometrist, within
15    the limits of their licenses, by  a  physician  assistant  in
16    accordance  with  subsection  (f)  of  Section  4,  or  by an
17    advanced practice nurse in accordance with subsection (g)  of
18    Section 4, containing the following: (l) name of the patient;
19    (2)  date when prescription was issued; (3) name and strength
20    of drug or description of the medical device prescribed;  and
21    (4)  quantity, (5) directions for use, (6) prescriber's name,
22    address and signature, and (7) DEA number where required, for
23    controlled substances. DEA numbers shall not be  required  on
24    inpatient drug orders.
25        (f)  "Person"   means  and  includes  a  natural  person,
26    copartnership, association, corporation,  government  entity,
27    or any other legal entity.
28        (g)  "Department"  means  the  Department of Professional
29    Regulation.
30        (h)  "Board of Pharmacy" or "Board" means the State Board
31    of Pharmacy of the Department of Professional Regulation.
32        (i)  "Director"  means  the  Director   of   Professional
33    Regulation.
34        (j)  "Drug product selection" means the interchange for a
 
                            -4-              LRB9105700ACtmam
 1    prescribed  pharmaceutical product in accordance with Section
 2    25 of this Act and Section 3.14 of the  Illinois  Food,  Drug
 3    and Cosmetic Act.
 4        (k)  "Inpatient  drug  order" means an order issued by an
 5    authorized prescriber for a resident or patient of a facility
 6    licensed under the Nursing Home  Care  Act  or  the  Hospital
 7    Licensing  Act,  or  "An  Act in relation to the founding and
 8    operation of the University  of  Illinois  Hospital  and  the
 9    conduct  of  University  of  Illinois  health care programs",
10    approved July 3, 1931, as amended, or  a  facility  which  is
11    operated by the Department of Human Services (as successor to
12    the   Department   of   Mental   Health   and   Developmental
13    Disabilities) or the Department of Corrections.
14        (k-5)  "Pharmacist"   means   an   individual   currently
15    licensed by this State to engage in the practice of pharmacy.
16        (l)  "Pharmacist in charge" means the licensed pharmacist
17    whose  name  appears on a pharmacy license who is responsible
18    for all aspects of the operation related to the  practice  of
19    pharmacy.
20        (m)  "Dispense"  means  the delivery of drugs and medical
21    devices, in accordance with applicable State and federal laws
22    and  regulations,   to   the   patient   or   the   patient's
23    representative   authorized   to   receive   these  products,
24    including the compounding, packaging, and labeling  necessary
25    for delivery, and any recommending or advising concerning the
26    contents  and therapeutic values and uses thereof. "Dispense"
27    does not mean  the  physical  delivery  to  a  patient  or  a
28    patient's  representative  in  a  home  or  institution  by a
29    designee of a pharmacist or by  common  carrier.   "Dispense"
30    also does not mean the physical delivery of a drug or medical
31    device   to  a  patient  or  patient's  representative  by  a
32    pharmacist's designee within a pharmacy  or  drugstore  while
33    the pharmacist is on duty and the pharmacy is open.
34        (n)  "Mail-order  pharmacy"  means  a  pharmacy  that  is
 
                            -5-              LRB9105700ACtmam
 1    located in a state of the United States, other than Illinois,
 2    that  delivers,  dispenses or distributes, through the United
 3    States Postal Service or other common  carrier,  to  Illinois
 4    residents, any substance which requires a prescription.
 5        (o)  "Compounding"   means   the   preparation,   mixing,
 6    assembling,  packaging,  or  labeling  of  a  drug or medical
 7    device: (1) as the result of  a  practitioner's  prescription
 8    drug  order  or  initiative  that  is dispensed pursuant to a
 9    prescription in the course of professional practice;  or  (2)
10    for  the  purpose  of, or incident to, research, teaching, or
11    chemical analysis; or (3)  in  anticipation  of  prescription
12    drug  orders based on routine, regularly observed prescribing
13    patterns.
14        (p)  "Confidential   information"   means    information,
15    maintained  by  the  pharmacist  in  the  patient's  records,
16    released  only (i) to the patient or, as the patient directs,
17    to other practitioners and other pharmacists or (ii)  to  any
18    other person authorized by law to receive the information.
19        (q)  "Prospective   drug  review"  or  "drug  utilization
20    evaluation" means a  screening  for  potential  drug  therapy
21    problems   due   to   therapeutic  duplication,  drug-disease
22    contraindications, drug-drug interactions (including  serious
23    interactions with nonprescription or over-the-counter drugs),
24    drug-food  interactions, incorrect drug dosage or duration of
25    drug treatment, drug-allergy interactions, and clinical abuse
26    or misuse.
27        (r)  "Patient counseling" means the communication between
28    a  pharmacist  or  a  student  pharmacist  under  the  direct
29    supervision of a pharmacist and a patient  or  the  patient's
30    representative  about  the patient's medication or device for
31    the  purpose  of  optimizing  proper  use   of   prescription
32    medications   or  devices.   The  offer  to  counsel  by  the
33    pharmacist  or  the  pharmacist's  designee,  and  subsequent
34    patient counseling by the pharmacist or  student  pharmacist,
 
                            -6-              LRB9105700ACtmam
 1    shall  be  made  in  a  face-to-face  communication  with the
 2    patient  or   patient's   representative   unless,   in   the
 3    professional  judgment  of  the  pharmacist,  a  face-to-face
 4    communication  is  deemed  inappropriate  or unnecessary.  In
 5    that instance, the offer to counsel or patient counseling may
 6    be made in a written communication, by  telephone,  or  in  a
 7    manner determined by the pharmacist to be appropriate.
 8        (s)  "Patient  profiles" or "patient drug therapy record"
 9    means the obtaining, recording, and  maintenance  of  patient
10    prescription and personal information.
11        (t)  "Pharmaceutical  care"  includes, but is not limited
12    to, the act of monitoring drug use  and  other  patient  care
13    services  intended  to  achieve  outcomes  that  improve  the
14    patient's  quality  of life but shall not include the sale of
15    over-the-counter drugs by a seller of goods and services  who
16    does not dispense prescription drugs.
17        (u)  "Medical  device"  means  an  instrument, apparatus,
18    implement, machine, contrivance, implant, in  vitro  reagent,
19    or  other similar or related article, including any component
20    part or accessory, required under federal  law  to  bear  the
21    label  "Caution: Federal law requires dispensing by or on the
22    order of a physician". A seller of goods  and  services  who,
23    only  for  the  purpose  of  retail  sales, compounds, sells,
24    rents, or  leases  medical  devices  shall  not,  by  reasons
25    thereof, be required to be a licensed pharmacy.
26    (Source: P.A.  89-202,  eff.  7-21-95;  89-507,  eff. 7-1-97;
27    90-116, eff. 7-14-97;  90-253,  eff.  7-29-97;  90-655,  eff.
28    7-30-98; 90-742, eff. 8-13-98.)".







[ Top ]